Data Bridge Market Research analyses a growth rate in the thrombocytopenia-absent radius (TAR) syndrome market in the forecast period 2023-2030. The expected CAGR of thrombocytopenia-absent radius (TAR) syndrome market is tend to be around 13 % in the mentioned forecast period. The market was valued at USD 0.94 billion in 2022, and it would grow up to USD 2.5 billion by 2030.